Autifony Therapeutics
We have focused science teams providing medicinal chemistry, molecular and cell biology, and electrophysiology expertise as well as a clinical team who are experienced in designing and leading clinical trials. Our track records highlight our use of non-invasive CNS biomarkers to demonstrate human CNS target engagement, enable patient stratification, and monitoring of treatment effect. The Autifony team also has unique experience of the design and implementation of clinical trials in hearing diso
Basic Information
- Category: business
- Website: http://www.autifony.com/
Documented Facts
- Phone: 765-106.6655 (No linked source recorded for this statement.)
- CEO: and Giuseppe Alvaro (No linked source recorded for this statement.)
Evidence and Sources
- Autifony Therapeutics — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Autifony Therapeutics.
- Canonical profile: https://brandsource.ai/brands/autifony-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/autifony-therapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/autifony-therapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
We have focused science teams providing medicinal chemistry, molecular and cell biology, and electrophysiology expertise as well as a clinical team who are experienced in designing and leading clinical trials. Our track records highlight our use of non-invasive CNS biomarkers to demonstrate human CNS target engagement, enable patient stratification, and monitoring of treatment effect. The Autifony team also has unique experience of the design and implementation of clinical trials in hearing diso
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.